JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
Voyager Therapeutics
VYGR
$152M
| $2.77M | ﹤0.01% |
359,741
+37,946
| +12% | +$302K |
2017 Q3
22 quarters
|
|
|
SGMO
3152
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.77M | ﹤0.01% |
1,574,172
+11,863
| +0.8% | +$33.9K |
2016 Q4
25 quarters
|
|
3153
iShares Core Universal USD Bond ETF
IUSB
$48.1B
| $2.77M | ﹤0.01% |
60,034
+19,446
| +48% | +$890K |
2020 Q2
11 quarters
|
|
3154
CALL
Super Micro Computer
SMCI
$28.6B
| $2.77M | ﹤0.01% |
+260,000
| New | +$2.35M |
2023 Q1
0 quarters
|
|
|
TRST
3155
Trustco Bank Corp NY
TRST
$939M
| $2.77M | ﹤0.01% |
86,626
-52,300
| -38% | -$1.88M |
2013 Q2
39 quarters
|
|
3156
ProShares S&P 500 ex-Technology ETF
SPXT
$286M
| $2.77M | ﹤0.01% |
+40,000
| New | +$2.77M |
2023 Q1
0 quarters
|
|
3157
PUT
3M
MMM
$84.4B
| $2.76M | ﹤0.01% |
31,455
-48,199
| -61% | -$4.55M |
2016 Q2
27 quarters
|
|
3158
Vanguard Morningstar Mega Cap Growth ETF
MGK
$35.5B
| $2.76M | ﹤0.01% |
67,420
-25,645
| -28% | -$972K |
2016 Q1
28 quarters
|
|
3159
PUT
Moody's
MCO
$78.3B
| $2.75M | ﹤0.01% |
9,000
| – | – |
2022 Q2
3 quarters
|
|
|
BBT
3160
Beacon Financial Corp
BBT
$2.34B
| $2.75M | ﹤0.01% |
109,745
+46,291
| +73% | +$1.32M |
2013 Q2
39 quarters
|
|
|
AYX
3161
CALL
DELISTED
Alteryx Inc
AYX
| $2.75M | ﹤0.01% |
+46,700
| New | +$2.72M |
2023 Q1
0 quarters
|
|
3162
CALL
Gold Fields
GFI
$32.2B
| $2.74M | ﹤0.01% |
+205,900
| New | +$2.29M |
2023 Q1
0 quarters
|
|
3163
WisdomTree US LargeCap Fund
EPS
$1.68B
| $2.74M | ﹤0.01% |
62,734
+3,520
| +6% | +$152K |
2022 Q1
4 quarters
|
|
3164
Ennis
EBF
$571M
| $2.74M | ﹤0.01% |
129,980
+7,083
| +6% | +$151K |
2013 Q2
39 quarters
|
|
3165
PUT
Upstart Holdings
UPST
$2.32B
| $2.74M | ﹤0.01% |
+172,400
| New | +$2.9M |
2023 Q1
0 quarters
|
|
3166
PUT
FirstEnergy
FE
$25.6B
| $2.74M | ﹤0.01% |
68,300
-64,000
| -48% | -$2.59M |
2021 Q3
6 quarters
|
|
|
IRBT
3167
PUT
DELISTED
iRobot
IRBT
| $2.74M | ﹤0.01% |
62,700
+62,600
| +62,600% | +$2.77M |
2022 Q4
1 quarter
|
|
3168
S&T Bancorp
STBA
$1.72B
| $2.73M | ﹤0.01% |
86,979
-195,867
| -69% | -$6.83M |
2013 Q2
39 quarters
|
|
3169
PUT
Moderna
MRNA
$74.8B
| $2.73M | ﹤0.01% |
17,800
-40,900
| -70% | -$6.75M |
2020 Q1
12 quarters
|
|
3170
PUT
STMicroelectronics
STM
$52.6B
| $2.73M | ﹤0.01% |
+51,000
| New | +$2.38M |
2023 Q1
0 quarters
|
|
|
DMC
3171
Del Monte Corp
DMC
$1.4B
| $2.71M | ﹤0.01% |
90,098
+26,066
| +41% | +$757K |
2013 Q2
39 quarters
|
|
|
SLCA
3172
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.71M | ﹤0.01% |
227,228
-101,583
| -31% | -$1.21M |
2015 Q4
29 quarters
|
|
|
GPP
3173
DELISTED
Green Plains Partners LP
GPP
| $2.71M | ﹤0.01% |
213,626
-19,474
| -8% | -$252K |
2018 Q1
20 quarters
|
|
3174
Polestar Automotive Holding UK
PSNY
$974M
| $2.71M | ﹤0.01% |
23,853
-1,139
| -5% | -$173K |
2022 Q4
1 quarter
|
|
3175
Weibo
WB
$1.59B
| $2.71M | ﹤0.01% |
135,226
+133,949
| +10,489% | +$2.74M |
2015 Q4
29 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.